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Significance	of	Pathophysiology	There	are	no	structural	abnormalities	within	the	gastrointestinal	system	to	explain	the	discomforts	associated	with	IBS.	Recent	research	shows	the	pathophysiology	of	IBS	is	multifactorial	and	evidence	suggests	several	factors	such	as	“motility,	inflammatory,	genetic,	immune,	psychological,	and	dietary	components”	can	contribute	to	the	development	of	IBS	(Snyder,	2018,	“Definition”).	
• Irritable	Bowel	Syndrome	(IBS)	is	one	of	the	most	common	functional	gastrointestinal	disorders.	IBS	causes	abdominal	pain	and	is	associated	with	altered	bowel	habits	(Dlugosz,	Zakikhany,	Acevedo,	D'Amato,	&	Lindberg,	2017,	p.	1).	
• IBS	affects	between	25	and	45	million	people	in	the	United	States.	About	2	in	3	IBS	sufferers	are	female (International	Foundation	for	Functional	Gastrointestinal	Disorders,	Inc	[IFFGD],	2018).
• IBS	is	estimated	to	affect	as	many	as	5-20%	of	individuals	worldwide	(SJFM,	2015,	para.	1).
• It	is	estimated	the	annual	health	care	cost	spent	on	IBS	in	the	United	States	is	$8	billion.	IBS	accounts	for	up	to	50%	of	 referrals	to	gastroenterologists,	making	it	the	most	common	cause	for	referrals	(Snyder,	2018).
• IBS	causes	a	variety	of	gastrointestinal	symptoms	ranging	from	mild	to	severe	and	is	divided	into	different	subtypes	based	on	symptomatology:		Diarrhea-predominant	IBS	(IBS-D),	constipation-predominant	IBS	(IBS-C),	and	mixed	diarrhea	and	constipation-predominant	IBS	(IBS-M).	While	IBS	is	not	known	to	cause	increased	mortality,	for	patients	suffering	with	IBS,	it	can	result	in	a	significantly	reduced	quality	of	life	(San	Jose	Functional	Medicine	[SJFM],	2015,	para.	1).
• IBS	can	cause	intense	discomfort	and	can	also	affect	a	patient’s	quality	of	life.	Therefore,	it	is	important	that	primary	care	providers,	such	as	Family	Nurse	Practitioners	(FNPs),	recognize	the	symptoms	associated	with	IBS,	correctly	rule	out	differential	diagnoses	through	thorough	assessment,	and	appropriately	refer	patients	to	gastroenterology	if	warranted.		Since	IBS	is	one	of	the	most	common	GI	disorders,	it	is	likely	FNPs	will	encounter	patients	suffering	from	the	disorder	during	their	career,	and	they	should	feel	comfortable	caring	for	patients	with	IBS	and	be	able	to	provide	patients	with	a	well-rounded	approach	to	IBS	symptom	management.	
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Implications	for	Nursing	Care
IBS	can	severely	impact	a	patient’s	quality	of	life,	and	it	is	crucial	that	health	care	providers	feel	comfortable	caring	for	patients	with	IBS.	The	pathophysiology	of	IBS	is	multifactorial	and	prompt	recognition	of	the	symptoms	of	IBS	can	result	in	maintaining	the	highest	level	of	quality	of	life	for	patients.	Practitioners	should	feel	comfortable	involving	other	specialties	and	utilizing	a	multidisciplinary	approach	when	providing	care	to	best	combat	the	several	compounding	factors	that	can	lead	to	the	development	of	IBS.	IBS	can	lead	to	mood	disorders	such	as	anxiety	and	depression	which	can	contribute	to	other	serious	co-morbidities.	
Conclusion
Signs	and	Symptoms
Diagnosis	of	IBS	by	predominant	stool	
pattern	using	the	Rome	IV	staging:1.	IBS	with	constipation	(IBS-C):	hard	or	lumpy	stools	for	≥25%	of	bowel	movements	and	loose	(mushy)	or	watery	stools	for	≤25%	of	bowel	movements.2.	IBS	with	diarrhea	(IBS-D):	loose	(mushy)	or	watery	stools	for	≥25%	of	bowel	movements	and	hard	or	lumpy	stool	for	≤25%	of	bowel	movements.3.	Mixed	IBS	(IBS-M):	hard	or	lumpy	stools	for	≤25%	of	bowel	movements	and	loose	(mushy)	or	watery	stools	for	≤25%	of	bowel	movements.4.	Unspecified	IBS:	insufficient	abnormality	of	stool	consistency	to	meet	criteria	for	IBS-C,	IBS-D,	or	IBS-M.(Snyder,	2018,	“Definition”).
Underlying	Pathophysiology
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• Abdominal	pain	and	discomfort
• Changes	in	bowel	habits,	frequency,	and	consistency	of	stool	(diarrhea,	constipation,	or	both).	
• Abdominal	cramps	
• Discomfort	or	pain	typically	relieved	after	a	bowel	movement
• Symptoms	occur	over	a	long	period	of	time	and	typically	come	and	goAbout	25%	to	50%	of	people	who	suffer	from	IBS	commonly	report	additional	GI	symptoms	including:
• Heartburn
• Early	feeling	of	fullness	(satiety)
• Nausea
• Abdominal	fullness
• Bloating[IFFGD],	2018,	“Signs	and	Symptoms”).
Inflammatory:	Intestinal	biopsies	and	measurements	of	cytokines	have	shown	that	chronic	low-level	inflammation	occurs	in	a	significant	number	of	IBS	cases	(Rountree,	2013,	p.	289).	In	some	IBS	patients,	GI	symptoms	appear	following	an	infection.	“Post-infectious	IBS	has	been	reported	after	viral,	bacterial,	protozoa	and	nematode	infections” (SJFM,	2015,	“Inflammation”).	Following	infection,	the	initial	inflammatory	response	results	in	an	increase	in	lymphocytes		and	macrophages.	The	inflammatory	response	typically	decreases,	however,	in	IBS	sufferers	there	are	persistent		GI	symptoms	consistent	with	low-grade	systemic	inflammation	(SJFM,	2015,	“Inflammation”).
Dysbiosis,	which	is	a	disruption	in	the	normal	balance	of	the	gut	microbiome,	is	now	being	recognized	as	a	major	contributing	factor	in	the	development	of	IBS.	(Rountree,	2013,	p.	289).
Genetic:	In	one	study,	up	to	33%	of	patients	with	IBS	had	a	family	history	of	IBS	compared	to	only	2%	of	the	controls	reporting	a	family	history.	Another	study	found	a	significant	association	between	having	a	first	degree	family	member	with	 reported	GI	symptoms	and	the	development	of	IBS,	suggesting	a	genetic	involvement	(SJFM,	2015,	“Heritability	and	Genetics”).
Immune:	Dlugosz	et	al.	found	significantly	upregulated	expression	of	toll-like	receptors	(TLR)	4,	5,	and	9	in	small	bowel	mucosa	of	patients	with	IBS.	These	increases	in	the	number	of		toll-like	receptors	suggests	an	impairment	of	the	immune	 system	response	to	normal	flora	in	the	small	bowel	mucosa	of	IBS	patients	(Dlugosz	et	al.,	2017,	p.	4).	
Psychological:	Coexisting	psychological	issues	are	believed	to	mediate	changes	in	gut	permeability,	contributing	to	the	development	of	IBS	symptoms.	This	brain–gut	theory	of	IBS	proposes	that	“an	abnormal	stress	response,	in	combination	with	psychological	distress	(e.g.,	anxiety,	depression,	or	somatization),	and	an	infectious	or	inflammatory	response	may	alter	intestinal	permeability	and	initiate	a	cascade	of	events	(e.g.,	infiltration	of	inflammatory	cells,	localized	edema,	and	release	of	cytokines	or	chemokines)	that	result	in	the	development	of	IBS	symptoms”	(Ford,	Lacy,	&	Talley,	2017,	p.	2568).	
Dietary:	Many IBS	patients	appear	to	be	sensitive	to	foods	containing	short-chain	carbohydrates	called	FODMAPs,	which	are	not	fully	digested	or	absorbed.	These	poorly	digested	carbohydrates	enter	the	small	intestine	and	colon	where	they	provide	a	substrate	for	bacterial	fermentation,	which	produces	gas	within	the	intestinal	tract.	This	distention	can	cause	the	abdominal	discomfort	associated	with	IBS	(SJFM,	2015,	”Does	Diet	Play	a	Role?”).
Ø IBS	is	associated	with	“high	psychological	and	medical	comorbidity,	increased	health-care	utilization,	decreased	work	productivity,	and	diminished	quality	of	life”	(Weaver,	Melkus,	&	Henderson,	2018,	p.	312).
Ø In	one	study,	over	half	of	the	1,966	patients	surveyed	reported	missing	employment,		academic,	and	social	activities	because	of	their	IBS	symptoms.		In	another	retrospective	metanalysis that	compared	results	of	18	studies,	employees	with	IBS	missed	on	average	between	8.5	to	21.6	days	of	work	annually	(Weinstock,	2018,	p.	3)
Ø While	stress	alone	does	not	cause	IBS,	due	to	the	connection	between	the	brain	and	the	gut,	stress	can	worsen	or	trigger	symptoms	[IFFGD],	2018,	“Facts	About	IBS”).	Symptoms	often	come	and	go,	making	it	difficult	to	predict	and	plan	around,	which	causes	additional	stress	in	patients	with	IBS.	
Ø IBS	symptoms	can	exacerbate	symptoms	of	mood	disorders	such	as	anxiety	and	depression,	which	then	increases	the	severity	of	the	gastrointestinal	symptoms	associated	with	IBS.	Developing	research	shows	that	in	up	to	50%	of	those	suffering	from	IBS,	the	gastrointestinal	discomforts	develop	first,	with	subsequent	development	of	mood	disorders	(Ford	et	al.,	2017,	p.	2568).	
Ø Nurses	and	providers	play	a	crucial	role	in	the	management	of	IBS	patients	and	“a	personalized	approach	to	patients	with	IBS	may	identify	etiological	and	perpetuating	mechanisms	behind	symptom	exacerbation	and	help	to	direct	medicinal,	nutritional,	psychological,	and/	or	physical	interventions	with	which	to	optimize	patient	care”	(Weaver	et	al.,	2018,	p.	319).	
Ø There	is	often	a	stigma	regarding	disorders	involving	the	bowels,	and	it	is	crucial	that	providers	develop	a	trusting	relationship	with	clients	where	they	feel	comfortable	openly	discussing	their	symptoms	and	concerns.
Ø Since	the	pathophysiology	of	IBS	is	so	multifactorial,	care	should	be	individualized	and	a	holistic	approach	should	be	taken.	It	is	crucial	providers	focus	not	only	on	the	physical	symptoms	of	IBS,	but	also	the	psychological	aspect	of	the	disease	and	the	affect	it	can	have	on	the	patient’s	overall	quality	of	life.
Ø Dietary	modifications	should	be	initiated	first,	specifically,	a	low	FODMAP	diet.	Exercise	and	stress-reduction	measures	should	also	be	encouraged	(Ford	et	al.,	2017,	p.	2576).	Referrals	to	a	gastroenterologist	and	a	nutritionist	should	be	considered	if	symptoms	are	severe	or	persist	despite	dietary	changes.	
Ø Patients	should	be	regularly	screened	for	depression	and	anxiety,	and	since	there	is	no	curative	treatment	for	IBS,	counseling	or	alternative	therapies	should	be	considered	if	the	patient	shows	interest.	
Ø Patients	should	be	encouraged	to	visit	online	educational	sites	and	be	provided	with	up-to-date	patient	education.	Additionally,	patients	might	benefit	from	joining	a	support	group	where	they	feel	comfortable	openly	discussing	their	IBS	symptoms	and	how	it	affects	their	quality	of	life.
